Many in Australia will object, but if it improves the system, meaning better access to innovative medicines, who cares where the change comes from? If it takes another country to flip the script on access in Australia, who cares whether it is the US or Uganda?
If we're incapable of delivering meaningful change, we should hope the US intervenes
June 23, 2026 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The 'Dispatched' Podcast - Series 5. Ep.29
August 21, 2026 - - Podcast -
IDT Australia targets profitability after reporting sharply narrowing loss
August 21, 2026 - - Latest News -
Opportunity #5 - From the hardest thing to secure to the easiest thing to get right
August 21, 2026 - - Latest News -
Biogen bolsters leadership ranks as it sharpens focus on patient access and innovation
August 21, 2026 - - Latest News -
Advent moves to acquire majority stake in NZCR Group
August 21, 2026 - -
Personalised mRNA cancer therapy clears Phase 3 milestone in resected melanoma
August 21, 2026 - - Latest News -
New Zealand researchers honoured for work tackling superbugs and blood cancer
August 20, 2026 - - Latest News

